Literature DB >> 33987121

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.

Laura Dumont1, Adriano Salaroli2, Lissandra Dal Lago1, Thierry Gil1, Thierry Pepersack1.   

Abstract

We report the case of a 76-year-old man presenting with reactive haemophagocytic lymphohistiocytosis (rHLH) in the setting of disseminated prostate cancer. This often fatal syndrome must be diagnosed early in order to maximize survival. Treatment should be initiated whenever the clinical diagnosis is suspected, even if the HLH-2004 criteria are not met. The HScore is a useful diagnostic tool for rHLH. In case of neurological symptoms, an extensive assessment must be performed. The goal of this case report is to raise awareness of this rare syndrome among oncologists. LEARNING POINTS: The association of prostate cancer and reactive haemophagocytic lymphohistiocytosis (rHLH) has rarely been described.This often fatal syndrome must be recognized early in order to start specific treatment and maximize survival.Specific treatment for rHLH must be accompanied by treatment of the triggering factors. © EFIM 2021.

Entities:  

Keywords:  HScore; Prostate cancer; hyperferritinemia; hypertriglyceridemia; pancytopenia; reactive hemophagocytic lymphohistiocytosis

Year:  2021        PMID: 33987121      PMCID: PMC8112095          DOI: 10.12890/2021_002425

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  6 in total

1.  The hemophagocytic syndrome in prostate cancer revealed by disseminated carcinomatosis of the bone marrow.

Authors:  K Koizumi; Y Haseyama; R Machino; Y Sato; K Sawada; T Koike
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

2.  Prostate cancer related haemophagocytic syndrome: successful treatment with chemotherapy.

Authors:  Lydie Declerck; Claude Adenis; Eric Amela; Armelle Caty; Antoine Adenis; Nicolas Penel
Journal:  Acta Oncol       Date:  2011-09-22       Impact factor: 4.089

3.  Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.

Authors:  Laurence Fardet; Lionel Galicier; Olivier Lambotte; Christophe Marzac; Cedric Aumont; Doumit Chahwan; Paul Coppo; Gilles Hejblum
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

4.  [Reactive hemophagocytic syndrome].

Authors:  Fiona Novotny; Federico Simonetta; Kaveh Samii; Yves Chalandon; Jacques Serratrice
Journal:  Rev Med Suisse       Date:  2017-10-18

5.  Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

Authors:  Elisabet Bergsten; AnnaCarin Horne; Maurizio Aricó; Itziar Astigarraga; R Maarten Egeler; Alexandra H Filipovich; Eiichi Ishii; Gritta Janka; Stephan Ladisch; Kai Lehmberg; Kenneth L McClain; Milen Minkov; Scott Montgomery; Vasanta Nanduri; Diego Rosso; Jan-Inge Henter
Journal:  Blood       Date:  2017-09-21       Impact factor: 22.113

6.  Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the "hook effect".

Authors:  H C Vaidya; B A Wolf; N Garrett; W J Catalona; R V Clayman; M H Nahm
Journal:  Clin Chem       Date:  1988-10       Impact factor: 8.327

  6 in total
  1 in total

1.  Reactive Hemophagocytic Lymphohistiocytosis Secondary to Ovarian Adenocarcinoma: A Rare Case Report.

Authors:  Xiao-Yan Li; Shu-Min Zhu; Xin-Yuan Li; Rui-Sheng Dong; Ai-Ai Zhang; Shu-Jing Li; Yu-Lan Geng
Journal:  J Inflamm Res       Date:  2022-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.